Clinical trials
Phase 1/2 Leukemia trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2008 | 1 |
| 2014 | 1 |
| 2016 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 4 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Completed | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Princess Maxima Center for Pediatric Oncology | 3 |
| Celgene | 2 |
| Incyte Corporation | 2 |
| Commissie Voor Klinisch Toegepast Onderzoek | 1 |
| Constellation Pharmaceuticals | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Glycostem Therapeutics BV | 1 |
| Incyte Biosciences International Sàrl | 1 |
| Kura Oncology, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 13 |
| Leukemia, Myeloid, Acute | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Recurrence | 4 |
| Myelodysplastic Syndromes | 3 |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Hematologic Neoplasms | 2 |
| Leukemia, Myeloid, Chronic-Phase | 2 |
| Lymphoma | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.